Related references
Note: Only part of the references are listed.ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Priya Kumthekar et al.
CLINICAL CANCER RESEARCH (2020)
Subtype switching in breast cancer brain metastases: a multicenter analysis
Alexander F. C. Hulsbergen et al.
NEURO-ONCOLOGY (2020)
Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model
Jun Yamamoto et al.
ANTICANCER RESEARCH (2020)
A Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft (PDOX) Mouse Model Is Sensitive to Bevacizumab and Vinorelbine, Regressed by Eribulin and Resistant to Olaparib
Jun Yamamoto et al.
ANTICANCER RESEARCH (2020)
A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model
Hye In Lim et al.
ANTICANCER RESEARCH (2020)
Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer
Aryana M. Razmara et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
M. E. Robson et al.
ANNALS OF ONCOLOGY (2019)
Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
Margarite D. Matossian et al.
BMC CANCER (2019)
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications
Francesca Nazio et al.
CELL DEATH AND DIFFERENTIATION (2019)
TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases
Rachel A. Freedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
Guillermo Prado-Vazquez et al.
SCIENTIFIC REPORTS (2019)
Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness
Kha-Liang Lee et al.
CANCERS (2019)
A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
Marcia Fournier et al.
SCIENTIFIC REPORTS (2019)
Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
Maria Laura De Angelis et al.
CANCERS (2019)
Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
Hyung Seok Park et al.
PLOS ONE (2019)
Brain metastases
Achal Singh Achrol et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Comparison of Local Control of Brain Metastases With Stereotactic Radiosurgery vs Surgical Resection A Secondary Analysis of a Randomized Clinical Trial
Thomas M. Churilla et al.
JAMA ONCOLOGY (2019)
Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer
Vishnu C. Ramani et al.
BREAST CANCER RESEARCH (2019)
Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis
Y. Bareche et al.
ANNALS OF ONCOLOGY (2018)
Incidence, pattern and prognosis of brain metastases in patients with metastatic triple negative breast cancer
Jia Jin et al.
BMC CANCER (2018)
Genetic alterations in sporadic triple negative breast cancer
Laura-Ancuta Pop et al.
BREAST (2018)
STAT3 as a promising chemoresistance biomarker associated with the CD44(+/high)/CD24(-/low)/ALDH(+) BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line
Milene Pereira Moreira et al.
EXPERIMENTAL CELL RESEARCH (2018)
STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
Neibla Priego et al.
NATURE MEDICINE (2018)
A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy
Layton Lamsam et al.
NEUROSURGICAL FOCUS (2018)
pSTAT3+ Reactive Astrocytes Promote Brain Metastasis
Minhong Shen et al.
TRENDS IN MOLECULAR MEDICINE (2018)
Autophagy promotes the survival of dormant breast cancer cells and metastatic tumour recurrence
Laura Vera-Ramirez et al.
NATURE COMMUNICATIONS (2018)
Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption
Costas D. Arvanitis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
PI3K: A master regulator of brain metastasis-promoting macrophages/microglia
Raquel Blazquez et al.
GLIA (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models
Roberto R. Rosato et al.
BREAST CANCER RESEARCH (2018)
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study
O. Kaidar-Person et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Final efficacy and updated safety results of the randomized phase III BEATRICE trial evaluating adjuvant bevacizumab-containing therapy in triple-negative early breast cancer
R. Bell et al.
ANNALS OF ONCOLOGY (2017)
Disrupting the blood-brain barrier by focused ultrasound induces sterile inflammation
Zsofia I. Kovacs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression
Ina Hohensee et al.
ONCOTARGET (2017)
The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
Fausto Petrelli et al.
EUROPEAN JOURNAL OF CANCER (2017)
Astrocytic tight junctions control inflammatory CNS lesion pathogenesis
Sam Horng et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial
Paul D. Brown et al.
LANCET ONCOLOGY (2017)
Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC)
Fei Ma et al.
MEDICINE (2017)
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation
Abdullah Al-Dhfyan et al.
MOLECULAR CANCER (2017)
Neurotoxic reactive astrocytes are induced by activated microglia
Shane A. Liddelow et al.
NATURE (2017)
Identification of diverse astrocyte populations and their malignant analogs
Chia-Ching John Lin et al.
NATURE NEUROSCIENCE (2017)
Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer
Amanda E. D. Van Swearingen et al.
NEURO-ONCOLOGY (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Exosomes: Key mediators of metastasis and pre-metastatic niche formation
Richard J. Lobb et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis
Xiao-lei Gao et al.
ONCOTARGETS AND THERAPY (2017)
Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases
Nolan Priedigkeit et al.
JAMA ONCOLOGY (2017)
Reactive Astrocytes in Brain Metastasis
David Wasilewski et al.
FRONTIERS IN ONCOLOGY (2017)
Guidelines for the Initial Management of Metastatic Brain Tumors: Role of Surgery, Radiosurgery, and Radiation Therapy
Matthew G. Ewend et al.
Journal of the National Comprehensive Cancer Network (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
Gabriella Frisk et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Dual PI3K and Wnt pathway inhibition is a synergistic combination against triple negative breast cancer
Jeffrey P. Solzak et al.
NPJ BREAST CANCER (2017)
Atezolizumab in metastatic TNBC (mTNBC): Long-term clinical outcomes and biomarker analyses
Peter Schmid et al.
CANCER RESEARCH (2017)
The Microenvironmental Landscape of Brain Tumors
Daniela F. Quail et al.
CANCER CELL (2017)
STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis
Laura M. Jones et al.
CANCER RESEARCH (2016)
miR-221/222 enhance the tumorigenicity of human breast cancer stem cells via modulation of PTEN/Akt pathway
Bailong Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling
Syn Kok Yeo et al.
CANCER RESEARCH (2016)
Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT
Srinivas Malladi et al.
CELL (2016)
miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation
Ivan Bahena-Ocampo et al.
EMBO REPORTS (2016)
Blood-brain Barrier Remodeling during Brain Metastasis Formation
Jagoda K. Wrobel et al.
MOLECULAR MEDICINE (2016)
Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying γ-secretase Inhibitors
Veronika Mamaeva et al.
MOLECULAR THERAPY (2016)
Metastatic colonization by circulating tumour cells
Joan Massague et al.
NATURE (2016)
CXCL12/CXCR4 Axis Improves Migration of Neuroblasts Along Corpus Callosum by Stimulating MMP-2 Secretion After Traumatic Brain Injury in Rats
Weifeng Mao et al.
NEUROCHEMICAL RESEARCH (2016)
The multifaceted role of autophagy in tumor evasion from immune surveillance
Bassam Janji et al.
ONCOTARGET (2016)
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
Jingdan Qiu et al.
JOURNAL OF CANCER (2016)
Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer The NEfERT-T Randomized Clinical Trial
Ahmad Awada et al.
JAMA ONCOLOGY (2016)
Wnt Signaling in Cancer Stem Cell Biology
Felipe de Sousa e Melo et al.
CANCERS (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer
Emily Powell et al.
BREAST CANCER RESEARCH (2016)
The use of stereotactic radiosurgery for brain metastases from breast cancer: Who benefits most?
Eunpi Cho et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers
Hyeong-Gon Moon et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment
O. van Tellingen et al.
DRUG RESISTANCE UPDATES (2015)
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases
Ishwaria M. Subbiah et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis
Akash J. Patel et al.
JOURNAL OF NEUROSURGERY (2015)
Autophagy Supports Breast Cancer Stem Cell Maintenance by Regulating IL6 Secretion
Paola Maycotte et al.
MOLECULAR CANCER RESEARCH (2015)
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer
Olga Karginova et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Lin Zhang et al.
NATURE (2015)
The role of taxanes in triple-negative breast cancer: literature review
Giorgio Mustacchi et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Hedgehog Signaling in the Maintenance of Cancer Stem Cells
Catherine R. Cochrane et al.
CANCERS (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
Biology, detection, and clinical implications of circulating tumor cells
Simon A. Joosse et al.
EMBO MOLECULAR MEDICINE (2015)
Circulating cancer stem cells: the importance to select
Ming-Hsin Yang et al.
CHINESE JOURNAL OF CANCER RESEARCH (2015)
Triple-Negative Breast Carcinoma Current and Emerging Concepts
Robert Schmadeka et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Autophagic degradation of GZMB/granzyme B
Elodie Viry et al.
AUTOPHAGY (2014)
Metastatic breast cancer subtypes and central nervous system metastases
C. Aversa et al.
BREAST (2014)
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
Carey Anders et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
Naoki Niikura et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain
Hava Karsenty Avraham et al.
JOURNAL OF PATHOLOGY (2014)
Pharmacodynamic and Therapeutic Investigation of Focused Ultrasound-Induced Blood-Brain Barrier Opening for Enhanced Temozolomide Delivery in Glioma Treatment
Hao-Li Liu et al.
PLOS ONE (2014)
Gliomas and the vascular fragility of the blood brain barrier
Luiz Gustavo Dubois et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases
Ina Hohensee et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients
D. W. Miles et al.
ANNALS OF ONCOLOGY (2013)
Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells
Haitao Zhu et al.
CANCER CELL INTERNATIONAL (2013)
Epithelial-to-Mesenchymal Transition and Autophagy Induction in Breast Carcinoma Promote Escape from T-cell-Mediated Lysis
Intissar Akalay et al.
CANCER RESEARCH (2013)
Mechanisms Governing Metastatic Dormancy and Reactivation
Filippo G. Giancotti
CELL (2013)
The CXCL12/CXCR4/CXCR7 ligand-receptor system regulates neuro-glio-vascular interactions and vessel growth during human brain development
Daniela Virgintino et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01)
Bernhard C. Pestalozzi et al.
LANCET ONCOLOGY (2013)
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot et al.
LANCET ONCOLOGY (2013)
The epigenetics of epithelial-mesenchymal plasticity in cancer
Wai Leong Tam et al.
NATURE MEDICINE (2013)
Targeting CXCL12/CXCR4 signaling with oncolytic virotherapy disrupts tumor vasculature and inhibits breast cancer metastases
Margaret Gil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
Joanna Baginska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combined Wnt/β-Catenin, Met, and CXCL12/CXCR4 Signals Characterize Basal Breast Cancer and Predict Disease Outcome
Jane D. Holland et al.
CELL REPORTS (2013)
A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype
Jonas Wolf et al.
BREAST CANCER RESEARCH (2013)
Stem cell marker aldehyde dehydrogenase 1 (ALDH1)-expressing cells are enriched in triple-negative breast cancer
Huihui Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
The roles of BECN1 and autophagy in cancer are context dependent
Chang Gong et al.
AUTOPHAGY (2012)
Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer
Shaheenah Dawood et al.
CANCER (2012)
EFFECT OF TUMOR SUBTYPE ON SURVIVAL AND THE GRADED PROGNOSTIC ASSESSMENT FOR PATIENTS WITH BREAST CANCER AND BRAIN METASTASES
Paul W. Sperduto et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
The extracellular matrix: A dynamic niche in cancer progression
Pengfei Lu et al.
JOURNAL OF CELL BIOLOGY (2012)
CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma
Yan Lin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Pearls and pitfalls of intraarterial chemotherapy for retinoblastoma A review
Pascal Jabbour et al.
JOURNAL OF NEUROSURGERY-PEDIATRICS (2012)
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah et al.
NATURE (2012)
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Sabine Kasimir-Bauer et al.
BREAST CANCER RESEARCH (2012)
CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target
Mizuhiko Terasaki et al.
BRAIN TUMOR PATHOLOGY (2011)
Autophagy positively regulates the CD44+CD24-/low breast cancer stem-like phenotype
Silvia Cufi et al.
CELL CYCLE (2011)
Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2011)
Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer
Yasuyo Ohi et al.
HISTOPATHOLOGY (2011)
A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition
Nam Hee Kim et al.
JOURNAL OF CELL BIOLOGY (2011)
Overcoming anoikis - pathways to anchorage-independent growth in cancer
Marta C. Guadamillas et al.
JOURNAL OF CELL SCIENCE (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
Adam M. Brufsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype
Sara Ricardo et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
Anna Niwinska et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
HDACs link the DNA damage response, processing of double-strand breaks and autophagy
Thomas Robert et al.
NATURE (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Transmigration of Melanoma Cells through the Blood-Brain Barrier: Role of Endothelial Tight Junctions and Melanoma-Released Serine Proteases
Csilla Fazakas et al.
PLOS ONE (2011)
Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer
Miguel Martin et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer
Panayiotis A. Theodoropoulos et al.
CANCER LETTERS (2010)
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
James E. Talmadge et al.
CANCER RESEARCH (2010)
Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain
Cimona V. Hinton et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
Microglia Promote Colonization of Brain Tissue by Breast Cancer Cells in a Wnt-Dependent Way
Tobias Pukrop et al.
GLIA (2010)
Nomogram to Predict Subsequent Brain Metastasis in Patients With Metastatic Breast Cancer
Olivier Graesslin et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
Evette S. Radisky et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours
Patrick Beauchesne
LANCET ONCOLOGY (2010)
Pericytes regulate the blood-brain barrier
Annika Armulik et al.
NATURE (2010)
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast et al.
NATURE MEDICINE (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
Survival among women with triple receptor-negative breast cancer and brain metastases
S. Dawood et al.
ANNALS OF ONCOLOGY (2009)
CXCL12, CXCR4 and CXCR7 Expression in brain metastases
Andrea Salmaggi et al.
CANCER BIOLOGY & THERAPY (2009)
The epidemiology of triple-negative breast cancer, including race
Katrina F. Trivers et al.
CANCER CAUSES & CONTROL (2009)
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
Florian Heitz et al.
EUROPEAN JOURNAL OF CANCER (2009)
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
Judith Hugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Loise M. Francisco et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Novel Drug Delivery Strategies in Neuro-Oncology
Dani S. Bidros et al.
NEUROTHERAPEUTICS (2009)
Activation of tumor cell integrin αvβ3 controls angiogenesis and metastatic growth in the brain
Mihaela Lorger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinical significance of basal-like subtype in triple-negative breast cancer
Yutaka Yamamoto et al.
BREAST CANCER (2009)
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
Bahriye Aktas et al.
BREAST CANCER RESEARCH (2009)
Sites of Distant Recurrence and Clinical Outcomes in Patients With Metastatic Triple-negative Breast Cancer High Incidence of Central Nervous System Metastases
Nancy U. Lin et al.
CANCER (2008)
Survival in patients with brain metastases from breast cancer
April F. Eichler et al.
CANCER (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Brain endothelial cell-cell junctions: How to Open the blood brain barrier
Svetlana M. Stamatovic et al.
CURRENT NEUROPHARMACOLOGY (2008)
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
Deann P. Atchley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Stepping out of the flow: capillary extravasation in cancer metastasis
Fayth L. Miles et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Breast cancer subtypes and survival in patients with brain metastases
Byung-Ho Nam et al.
BREAST CANCER RESEARCH (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
HER2 and response to paclitaxel in node-positive breast cancer
Daniel F. Hayes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Autophagy suppresses tumor progression by limiting chromosomal instability
Robin Mathew et al.
GENES & DEVELOPMENT (2007)
ABT-888, an orallyactive poly(ADP-ribose) polymerase inhibitor that potentiates DNA-damaging agents in preclinical tumor models
Cherrie K. Donawho et al.
CLINICAL CANCER RESEARCH (2007)
Beyond tumorigenesis: cancer stem cells in metastasis
Feng Li et al.
CELL RESEARCH (2007)
In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain
Chris Heyn et al.
MAGNETIC RESONANCE IN MEDICINE (2006)
Systemic high-dose intravenous methotrexate for central nervous system metastases
AB Lassman et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse
H Hikino et al.
BREAST (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Chemopotentiation by PARP inhibitors in cancer therapy
L Tentori et al.
PHARMACOLOGICAL RESEARCH (2005)
Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a Phase I/II clinical study
Z Lidar et al.
JOURNAL OF NEUROSURGERY (2004)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
CCL2 (monocyte chemoattractant protein-1) and cancer
I Conti et al.
SEMINARS IN CANCER BIOLOGY (2004)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation
MA Petty et al.
PROGRESS IN NEUROBIOLOGY (2002)
Integrin activation controls metastasis in human breast cancer
B Felding-Habermann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
YS Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
